Dr. PRP Kit

“We are proud to have received the necessary clearances to effectively market our best-in-class PRP kits, opening new markets and bringing PRP technology to people everywhere.” – George Bretz, Managing Partner of Dr. PRP USA.

STAFFORD, Texas (PRWEB)
June 21, 2023

Dr. PRP USA LLC is proud to announce it has received 510K approval from the Food & Drug Administration (FDA) for its PRP kits. Now that the 510K clearance is final, Dr. PRP can continue to expand its market providing PRP kits to medical providers.

“We are so proud that we have received the necessary clearances to effectively market our best-in-class PRP kits,” said George Bretz, Managing Partner of Dr. PRP USA.

The 510K approval or clearance is so named because it comes from Section 510(k) of the Food, Drug and Cosmetic Act requiring device manufacturers who must register to notify FDA of their intent to market a medical device at least 90 days in advance. This is known as a Premarket Notification – also called a PMN – a premarket submission made to FDA to demonstrate that the device to be marketed is safe and effective.

Bretz, a cardiovascular perfusionist and a leader in the U.S. healthcare industry for over 36 years with a passion for introducing innovative techniques, says he looks forward to the widespread availability of PRP technology, opening new markets and bringing PRP to people everywhere.

Platelet rich plasma (PRP) therapy involves removing, processing, and re-introducing an individual’s own cells to treat or prevent a medical condition. The process involves collecting a small amount of blood and spinning it in a centrifuge machine to separate the platelets from the red blood cells. PRP treatment has been in increasingly wide use for the past decade but is now being brought to the center of the U.S. medical market and is now actively being used in various medical fields.

PRP treatment is especially helpful in supporting wound healing after surgery, severe injury, or trauma. Originally developed in the 1970s, PRP was first used during open heart surgery in the late 1980s as an aid in healing. Thereafter, post-surgical PRP injections began being used in procedures where tissues have notoriously long recovery times. But PRP has even wider applications.

In the past decade, the technique has been used to address aesthetic conditions like male pattern baldness, and its clinical applications have ranged from staving off knee replacements to treating carpal tunnel syndrome. PRP’s clinical use to promote the body’s own natural healing capabilities holds incredible medical promise.

Because the treatments use a patient’s own tissues, PRP injections are safe and can be administered alone or used in conjunction with other procedures.

Before the 510K clearance, the PRP kits provided by Dr. PRP USA had already been contracted for sale to the Department of Veterans Affairs through close cooperation with YTS Global, Inc., an American service-disabled veteran-owned medical and surgical supply government contractor. Dr. PRP USA distributes the PRP kits used, and its product line approval was upgraded by the federal government as a quality-assured medical device. But now Dr. PRP USA has received a full 510K clearance from the FDA as well.

For medical suppliers or medical providers interested in learning more about the Dr. PRP USA line of PRP kits, you may reach the company directly at 844-377-7787. Additional information can also be found on the company’s website: https://www.drprpusa.com.

About Dr. PRP USA LLC

Dr. PRP USA LLC offers the most advanced and affordable PRP Preparation System on the market. Dr. PRP USA LLC is a privately held American company committed to introducing advanced, sophisticated, more effective, and naturally healthier medical technologies like PRP therapy into the American healthcare system. Dr. PRP’s dedicated research and development has paved the way for new products like the Dr. PRP Regenerative Therapy Kit, which is a simple and highly functional aid for separating platelets used in regenerative therapy. Dr. PRP USA’s product line for PRP collection has been registered by the FDA for regenerative use by healthcare providers in labs, treatment facilities, and med spas, and its FDA 510K has received full clearance.

Share article on social media or email:

BMI team exhibiting at FACRAO 2023

The issues registrars face are often similar across the board. It’s tough to use hard copy records when you’re getting transcript requests, so we help by digitizing the records and making them significantly more usable.

SUNNYVALE, Calif. (PRWEB)
June 21, 2023

The Florida Association of Collegiate Registrars and Admissions Officers (FACRAO) hosted higher education records officers in Orlando, FL, and is BMI’s first conference of the 2023 summer season.

BMI has been working with educational organizations for decades, and meeting the folks in charge of records at conferences like FACRAO is essential to understanding the problems that face records managers.

Hard copy paper files are prevalent in colleges and university archives, making transcript requests manual and time-consuming. Add to that scenario that many of the records are still on microfilm and microfiche and it’s obvious that a digital solution can substantially increase the operations of these officers.

Jake Walker, Account Executive, says that “I’ve worked with close to or maybe even over a hundred registrars since I’ve been with BMI, and the issues they face are often similar across the board. It’s tough to use hard copy records when you’re getting transcript requests or things of that sort, so we help by digitizing the records and making them significantly more usable.

Lots of my clients like our Digital ReeL application – especially when there’s microfilm and microfiche involved. It’s been great seeing how much more effective my clients are once they make the leap to digitized records.”

About BMI

BMI Imaging Systems (originally Bay Microfilm Incorporated) incorporated in 1958 as a microfilm service bureau, working with County Recorders to archive land records on microfilm. In the early 1960s, services were expanded to include preservation microfilming of the rare books and manuscripts of leading California Universities. A Library Microfilms Division was also established, working with over 200 newspaper publishers to preserve California local history for libraries and archivists. A reputation for service, precision, and reliability led to steady expansion of BMI’s government, education, and commercial clients over the next two decades. By the early 1990’s, the records management industry had entered the digital age and BMI was at the forefront of this evolution. Clients were meeting their electronic document management needs by having BMI digitize their records, with BMI installing and supporting on-site document management software solutions.

Today, BMI’s production capability includes two imaging facilities with a staff of more than 60 technicians. With a focus on quality, accuracy, security, and innovation, BMI provides custom solutions that fit the unique requirements of each of its customers. In addition to providing document/microform imaging and indexing services of the highest standard, BMI offers public tenant, private tenant, and CJIS (Criminal Justice Information Services)-compliant community cloud hosting services, enabling secure access to client data via the Web. BMI also provides systems integration services, implementing turnkey document capture, management, and workflow solutions. BMI employs an in-house software development staff, a project management customer support staff, along with IT professionals that support internal and Web hosting operations.

Share article on social media or email:

“Tattoo removal has given me back some autonomy to my body and cleared out space for me to find the right artist for my next piece without the old tattoo limiting their creative freedom.” – Faye, Removery Artist Partner

SAN LEANDRO, Calif. (PRWEB)
June 21, 2023

Removery, the world’s tattoo removal experts, is marking milestone openings in the United States and Canada. On June 27, the company will surpass 150 locations, globally, with studio openings in two countries: one in San Leandro, CA and one in Mississauga, ON.

The San Leandro studio will be located in Fashion Faire Place shopping center on the corner of Fairmont Drive and Hesperian Blvd. Removery will be between Footlocker and Verizon and across the parking lot from both Michaels and Ross Dress for Less.

“We are constantly looking for ways to better serve our clients,” says Matt Spencer, Regional Manager at Removery. “By establishing our San Leandro studio, we’re completing the ‘Removery Triangle’ along with our Walnut Creek and Emeryville locations. This new addition is a game-changer, as it means less time spent in traffic for the East and South Bay neighborhoods to access safe and effective tattoo removal options.”

At Removery, collaboration is key. The company’s Artist Partner Program is reflective of this ethos by offering complimentary tattoo removal treatments to tattoo artists and empowering their clients to remove or update an old tattoo by offering a trusted, effective solution for their tattoo removal and fading needs.

Faye, a tattoo artist local to the Bay Area and Removery client, reflects on her tattoo removal journey, “the Bay Area is full of people from so many backgrounds and situations, Removery provides a safe, non-judgmental space to educate and help people change or remove a tattoo.”

“Tattoo removal has given me back some autonomy to my body and cleared out space for me to find the right artist for my next piece without the old tattoo limiting their creative freedom,” Faye continues.

Removery’s research empowers its tattoo removal specialists to deliver the safest, most effective, and most accessible laser tattoo removal procedures using the state-of-the-art PicoWay® laser system. Removery is home to the world’s first tattoo removal Clinical Advisory Board dedicated to the advancement of the industry and has performed over 900,000 treatments. In addition to the 130 locations in the United States, Removery has nine locations in Canada and 12 in Australia.

Removery’s San Leandro studio, located at 15100 Hesperian Blvd, Suite 212, is approximately 1,800 square feet with two treatment rooms and one consultation room. Regular business hours are 10 a.m. to 6 p.m. Tuesday through Friday and 9:30 a.m. to 1:45 p.m. on Saturdays.

New clients to this location who purchase a complete removal package by July 13 will receive $350 off. To schedule an appointment, please call 866-602- 2561 or visit removery.com and connect with Removery on Instagram (@removery) or Facebook (@removery).

About Removery

Removery, the world’s tattoo removal experts, helps people reflect on the outside, who they are on the inside. Born from the partnership of North America’s four largest and most trusted tattoo removal brands, the company is committed to driving research and advancements in the world of laser tattoo removal while ensuring client safety and effective results. Removery is home to the world’s first tattoo removal Clinical Advisory Board dedicated to the advancement of the industry.

Share article on social media or email:

Providing compassionate care in the comfort of your own home, where kindness and comfort embrace each day.

LAS VEGAS (PRWEB)
June 21, 2023

As the demand for reliable and compassionate in-home health care continues to grow, Assisting Hand Home Care recognizes the importance of providing comprehensive services tailored to the unique needs of each client. By expanding its reach to Las Vegas, Paradise, and Henderson, NV, the agency aims to serve a wider population and bridge the gap in accessible and high-quality care for the community.

• 
  Wide Range of Specialized Care: Assisting Hand Home Care offers a wide range of specialized in-home health care services to meet the diverse needs of its clients. From companionship to personal care, overnight care, veteran home care, and more their team of dedicated professionals is equipped to provide customized care plans that promote well-being and independence.
• Highly Qualified and Compassionate Caregivers: Assisting Hand Home Care understands the importance of trust and peace of mind when it comes to choosing caregivers. They maintain a rigorous selection process to ensure that only highly qualified and compassionate caregivers join their team. Each caregiver undergoes thorough background checks, training, and ongoing professional development to guarantee the highest standards of care.
• Person-Centered Approach: Assisting Hand Home Care adopts a person-centered approach to care, recognizing the unique needs and preferences of each client. They work closely with clients and their families to develop individualized care plans that encompass physical, emotional, and social well-being. This commitment to personalized care fosters a nurturing environment and enhances the overall quality of life for clients.

Assisting Hand Home Care is delighted to bring its trusted in-home health care services to the South-Central Las Vegas community. With a commitment to compassion, quality, and personalized care, they aim to make a positive difference in the lives of their clients and their families.

About Assisting Hand Home Care: Assisting Hand Home Care is a trusted provider of in-home health care services, dedicated to improving the lives of individuals and families in South Central Las Vegas, NV, Henderson, and Paradise. With a wide range of specialized care options and a focus on personalization, Assisting Hand Home Care offers exceptional services that promote well-being and independence. Their team of highly qualified and compassionate caregivers is committed to delivering excellence in care.

For a complimentary consultation, please call us at (725) 696-9942

Share article on social media or email:

Options Medical Weight Loss clinic opening this summer in Fishers, IN.

“When you come to Options, you will have a qualified and compassionate care team dedicated to you. ” Dr. Matthew Walker, CEO of Options Medical Weight Loss.

FISHERS, Ind. (PRWEB)
June 21, 2023

Options Medical Weight Loss, a leading provider of personalized and effective weight loss solutions, is proud to announce the opening of its newest clinic in Fishers, Indiana. This state-of-the-art facility will be the first Options Medical Weight Loss location in the greater Indianapolis area. It is set to open its doors to the public in August 2023.

Options Medical Weight Loss has built a reputation for its innovative approach to non-surgical weight loss, combining medical expertise, comprehensive health coaching, and cutting-edge weight loss programs to help individuals achieve their weight loss goals. The new Fishers clinic will provide residents with a wide range of personalized weight loss options. Options Medical Weight Loss provides a variety of services, including personalized meal plans, prescription weight loss medications, lipotropic fat burning injections, metabolic analysis and health coaching. Each program is tailored to the individual, ensuring a personalized approach that maximizes results.

“We’re thrilled to bring Options Medical Weight Loss to Indianapolis! When you come to Options, you will have a qualified and compassionate care team dedicated to you. Your care team is led by our Chief Medical Officer, Dr. Katrina Mattingly who is Board Certified in Obesity Medicine, as well as specialist care provided by our medical providers (NPs & PAs), weight loss health coaches and patient care advocates. Care teams work collaboratively to help each patient reach their weight loss goal,” said Dr. Matthew Walker, CEO of Options Medical Weight Loss.

The opening of Options Medical Weight Loss in Fishers represents an exciting milestone for the company as it expands its presence in Indiana. With its proven track record and commitment to delivering outstanding results, Options Medical Weight Loss is poised to become the go-to destination for medical weight loss solutions in the greater Indianapolis area.

Patients can start their journey by signing up for a free consultation and metabolic scan on our website or by calling 888-405-LOSE (5673).

About Options Medical Weight Loss:

Options Medical Weight Loss was founded in 2014 in Chicago, Illinois and has since opened locations throughout Illinois, Ohio, Florida, Arizona and now Indiana, with continued plans to expand to more states. Options Medical Weight Loss has helped more than 25,000 patients achieve their weight loss goals.

Share article on social media or email:

Aerial view of Cannon Memorial Hospital

“Enhancing our patient rooms with MEDI+SIGN’s solution positions us for outstanding patient communication and care.”- Chuck Mantooth, Appalachian Regional Healthcare System’s CEO.

SMITHSBURG, Md. (PRWEB)
June 21, 2023

Appalachian Regional Healthcare System (ARHS) upgrades Charles A. Cannon Jr. Memorial Hospital (Cannon Memorial Hospital) with technological enhancements, including the implementation of MEDI+SIGN Digital Whiteboards and MEDI+SIGN Digital Door Displays, aligning with ARHS’s commitment to providing top quality patient care.

With a shared vision to provide robust specialty care, ARHS recently joined UNC Health to lead transformational change in primary care to improve lives in the High Country region of North Carolina. Through a comprehensive, long-term Management Services Agreement (MSA) between the two organizations, ARHS can invest in services, technology, equipment, and facilities.

Cannon Memorial Hospital, an ARHS member, is designated as a Critical Access Hospital (CAH) to ensure long-term operational and financial viability and to better extend services to the local community.

Cannon Memorial Hospital ranked in the top 5% of healthcare providers in delivering patient experience last year, winning them the 2022 Human Experience (HX) Guardian of Excellence Award® by Press Ganey. “Our mission to improve the overall safety, quality, and experience of care to our patients moves us to constantly seek out improvements to our processes and technology,” says Chuck Mantooth, Appalachian Regional Healthcare System’s CEO. “Enhancing our patient rooms with MEDI+SIGN’s solution positions us for outstanding patient communication and care.”

The inpatient rooms at Cannon Memorial Hospital feature upgrades from the outdated dry-erase whiteboards and static door signs to fully automated and real-time 43” digital in-room whiteboards and 15.6” door displays to help keep patients and families better informed about their care. The solution also improves safety with real-time alerts for patients attempting to leave the bed by providing visual and spoken audio warnings. MEDI+SIGN also helps staff ensure that care boards update in real-time with automatic data flows from the electronic medical record and other connected sources.

“The MEDI+SIGN electronic patient room whiteboards replace the traditional dry-erase boards in the patient rooms eliminating manual entry, drastically increasing staff satisfaction,” says David Linetsky, Founder/CEO of MEDI+SIGN. “The door displays provide an overview of any patient isolation procedures, safety alerts, precautions, and other risks to the healthcare team. These patient safety enhancements drastically streamline the coordination of care.”

MEDI+SIGN is the perfect partner being fully integrated with Allscripts®, ARHS’s current electronic medical record (EMR), and Epic®, UNC’s current EMR, to display the patient’s real-time healthcare data to clinicians, patients, and their families. MEDI+SIGN also uses data from ARHS’s Real-Time Locator System (RTLS) to support rounding initiatives, providing peace of mind to the patient and family.

MEDI+SIGN focuses on improving HCAHPS and ensuring patient safety by reducing falls and other sentinel events. Cannon Memorial Hospital’s smart beds integrate with MEDI+SIGN ANTI-FALL™ technology to alert healthcare staff, patients, and families of potential fall risks by sending alerts to the digital whiteboards in the patient’s room and the hallway. Patented algorithms use the information in the patient’s electronic health record to detect the patient’s fall risk and other factors to determine if the smart bed is in its safest position.

About Cannon Memorial Hospital

Charles A. Cannon, Jr. Memorial Hospital, a member of Appalachian Regional Healthcare System, is an 8-bed critical access hospital. The full-service emergency department, imaging department, laboratory, outpatient behavioral health, and Rehabilitation Center offering physical and occupational therapies round out the list of services. Conveniently located in Linville, the center point of Avery County, Cannon Memorial Hospital is fully accredited by the Joint Commission for the Accreditation of Healthcare Organizations. For more information, visit apprhs.org/cannon/.

About Appalachian Regional Healthcare System

Appalachian Regional Healthcare System (ARHS) is comprised of three hospitals, fifteen medical practices, a cancer center, a heart and vascular center, a pain management center, a rehabilitation center, and a healthcare foundation. ARHS is committed to Making Life Better through providing medical treatment, preventing illness, educating the healthcare professionals of tomorrow, researching new ways to fight disease, and working in our community to build a healthier High Country. For more information, visit apprhs.org.

About UNC Health

UNC Health is a state entity and an affiliated enterprise of the University of North Carolina system, comprised of 14 hospitals, 18 hospital campuses and more than 500 clinics along with the clinical patient care programs of the UNC School of Medicine (SOM). It exists to improve the health and well-being of North Carolinians and others we serve and to further the teaching mission of the University of North Carolina SOM. Over the past three years, UNC Health has provided more than $400 million in uncompensated or charity care to the citizens of North Carolina. Our hospitals have received numerous awards and recognition for quality care, patient safety and the overall patient experience. For more information, please visit unchealth.org.

About MEDI+SIGN

MEDI+SIGN is a game-changing communication tool used by hospitals that are pursuing the creation, improvement, and sustainability of their quality and safety goals. Driven and perfected by evidence-based outcomes, MEDI+SIGN deploys strategies tailored to the hospital’s specific needs and existing workflows. This unique approach allows hospitals to experience quality and safety transformations without negatively impacting the day-to-day workflow of staff. MEDI+SIGN is the first and only patient-facing technology in its class that requires zero effort from clinical staff while reinvesting time back to the bedside. With patient experience and complex psychology at the epicenter of this technology, patients are kept informed, satisfied, and safe. Beyond patient experience, MEDI+SIGN focuses on improving HCAHPS and increasing patient safety by preventing falls as well as other sentinel events related to HAC, among other CMS programs. To experience these results for yourself, visit medisigndisplays.com.

Allscripts is a registered trademark of Allscripts Healthcare LLC

Epic is a registered trademark of Epic Systems Corporation

MEDI+SIGN is a registered trademark. © 2023 MEDI+SIGN® All Rights Reserved

Share article on social media or email:

This comprehensive course teaches the evidence, knowledge and skills to conduct intensive therapeutic lifestyle interventions to better alleviate the many debilitating effects of type 2 diabetes

ST. LOUIS, Mo. (PRWEB)
June 21, 2023

The American College of Lifestyle Medicine (ACLM) has announced a new Type 2 Diabetes Remission Certificate to be awarded to physicians and eligible health professionals that signifies specialized knowledge and competency in evidence-based lifestyle medicine to support the treatment, remission, and prevention of type 2 diabetes and reversal of insulin resistance.

Physicians and eligible health professionals earn the certificate by completing “Remission of Type 2 Diabetes and Reversal of Insulin Resistance with Lifestyle Medicine,” an 18-hour continuing medical education/continuing education (CME/CE) course created by experts and researchers with proven success treating patients with type 2 diabetes using lifestyle medicine. The course discusses the role of nutrition, physical activity, sleep and other essential factors, and reviews the current literature around medication deprescribing for type 2 diabetes remission and reversal of insulin resistance, as well as definitions and success rates.    

About 37 million Americans have diabetes and 96 million adults have prediabetes, according to the U.S. Centers for Disease Control and Prevention. Type 2 diabetes is expected to increase by 673% in Americans younger than 20 by 2060 at the current trajectory.

“This comprehensive course teaches the evidence, knowledge and skills to conduct intensive therapeutic lifestyle interventions to better alleviate the many debilitating effects of type 2 diabetes,” says ACLM’s Founding President John Kelly, MD, MPH, LM Intensivist, FACLM, and lead faculty instructor for the course. “It is appropriate for the Type 2 Diabetes Remission Certificate to recognize physicians and eligible health professionals for taking the initiative to develop this unique skillset, which will be increasingly valued by both patients and health care employers as the prevalence of type 2 diabetes continues to increase in the U.S. and the world.”

Physicians, certified diabetes care and education specialists, physician associates, nurse practitioners, nurses, registered dietitians and pharmacists are among the health professionals eligible to earn the certificate. Certificate eligibility criteria were determined based on those working in direct patient care related to a diabetes diagnosis.

A certificate badge signifying completion of the course will accompany the names of ACLM members in the organization’s membership directory, as well as in lifestylemedpros.org, ACLM’s searchable online directory where patients can search for and connect with certified clinicians in their areas. More than 700 health professionals have enrolled in the course since it launched in 2020 and those eligible health professionals who have completed the course to date will also receive a certificate.

Lifestyle behavior changes are the first treatment option in type 2 diabetes clinical practice guidelines, but too few clinicians have the education and knowledge to conduct appropriately-dosed and effective lifestyle interventions. A 2022 expert consensus statement published by ACLM, endorsed by the American Association of Clinical Endocrinology, supported by the Academy of Nutrition and Dietetics, and co-sponsored by the Endocrine Society, concluded that sufficiently intensive lifestyle interventions can produce remission of type 2 diabetes with similar success to bariatric surgery, with substantially fewer side effects. ACLM’s course includes information on how to establish reimbursable intensive therapeutic lifestyle change programs.

“As an endocrinologist, I know first-hand the frustration of treating patients with ongoing and ever-increasing medication management that may slow, but not halt, progression of type 2 diabetes,” said Dr. Mahima Gulati, MD, DipABLM, FACLM, medical director of Lifestyle Medicine at Connecticut’s Middlesex Health Hospital. “I see in my clinical practice type 2 diabetes being diagnosed at younger and younger ages, which has the potential to shorten an affected patient’s life expectancy by years, if not decades. ACLM’s ‘Remission of Type 2 Diabetes and Reversal of Insulin Resistance with Lifestyle Medicine’ course is an in-depth, evidence-based training that equips clinicians with the knowledge and skills to provide patients a safe, effective and affordable treatment to help them treat the root cause of their disease. This option should be available to every person who suffers from type 2 diabetes.”

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole-person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management.

Share article on social media or email:

“The GI Genius intelligent endoscopy module has the potential to make a world-changing impact and we’re thrilled to recognize Medtronic for this achievement”

LOS ANGELES (PRWEB)
June 21, 2023

AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Medtronic plc, the leading global healthcare technology company, has been selected as winner of the “Best Deep Learning Platform” award in the sixth annual AI Breakthrough Awards program, recognizing the breakthrough innovation of Medtronic’s GI Genius™ system.

The GI Genius™ system, developed by Cosmo Intelligent Medical Devices, is an intelligent endoscopy module that uses AI to assist physicians in detecting polyps, in real-time, during a colonoscopy procedure. GI Genius is the first FDA authorized computer-aided detection (CADe) system using AI to help endoscopists identify colorectal polyps, regardless of shape, size, or morphology.

GI Genius leverages deep learning to support a clinician’s assessment of diagnostic images as it supplements colonoscopies with real-time image analysis of any colonoscopy video and scans every visual frame of the procedure to alert physicians to the presence of lesions – including small, flat polyps that can go undetected by even the most trained human eye.

Additionally, the software built into GI Genius has a robust dataset of more than 13 million polyp images and, as the datasets grow, the intelligent endoscopy module continues to learn, increasing better performance and accuracy. A recent announcement showcased the vision of GI Genius’ capability of hosting multiple AI algorithms.

“It’s an honor to have GI Genius selected for this award,” said Giovanni Di Napoli, president of the Medtronic Gastrointestinal business, which is part of the Medical Surgical Portfolio at Medtronic. “Our aim is to improve colonoscopies and increase early detection of potentially precancerous colorectal polyps. GI Genius doesn’t get tired or distracted, and it augments human intelligence with the potential to transform the way healthcare is delivered. Our expanding AI capabilities at Medtronic create opportunities to deliver against unmet needs, including across the Gastrointestinal (GI) practice.”

The mission of the AI Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of AI and machine learning related categories, including Generative AI, Computer Vision, AIOps, Deep Learning, Robotics, Natural Language Processing, industry specific AI applications and many more. This year’s program attracted more than 3,200 nominations from over 20 different countries throughout the world.

“The GI Genius intelligent endoscopy module has the potential to make a world-changing impact and we’re thrilled to recognize Medtronic for this achievement. Colorectal cancer is the second-leading cause of cancer related deaths in the U.S., yet 90% of people can beat it if diagnosed early. Screening is one of the most effective ways of doing that. However, colonoscopy is difficult, and polyps may be difficult to find,” said James Johnson, managing director, AI Breakthrough. “Congratulations to Medtronic. This world-changing, AI-driven innovation couldn’t come at a more pressing time as gastroenterologists manage an overwhelming backlog of colonoscopies.”

In the past two years since FDA authorization, Medtronic’s facilitation of the Health Equity Assistance Program provided 130 GI Genius units to underserved communities that otherwise would not receive the technology.

####

About AI Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the AI Breakthrough Awards program is devoted to honoring excellence in Artificial Intelligence technologies, services, companies and products. The AI Breakthrough Awards provide public recognition for the achievements of AI companies and products in categories including AI Platforms, Robotics, Business Intelligence, AI Hardware, NLP, Computer Vision and more. For more information visit AIBreakthroughAwards.com.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Share article on social media or email:

“To truly support our students as they journey through their educational careers and prepare to enter the workforce, particularly with careers tied to STEM education, we must address the fundamental skills necessary for success, which include math,” said Dr. Sandra Elliott.

COLORADO SPRINGS, Colo. (PRWEB)
June 21, 2023

TouchMath, a multisensory math program that makes learning critical math concepts accessible and clear for students who struggle to understand grade-level content, announces the publication of its comprehensive report, “The Transformative Potential of Early Screening for Dyscalculia, The Discounted Specific Learning Disability.” Widely underdiagnosed, dyscalculia is a neurodevelopmental learning disorder estimated to affect 5-7% of the worldwide population. Early screening for dyscalculia and evidence-based interventions are critical to addressing the learning disorder’s short- and long-term personal and social impacts. The whitepaper, co-authored by Dr. Sandra Elliott and doctoral candidate Sam Wertheim, seeks to increase awareness and understanding of dyscalculia and promote efforts to ensure that all children have access to the support they need.

“We know from routine screenings for hearing, vision, and dyslexia, that early identification and interventions work,” said Dr. Sandra Elliott, Chief Academic Officer at TouchMath and co-author of the whitepaper. “Most students with dyscalculia, if diagnosed at all, are not diagnosed until the third grade or later, after performing poorly on standardized tests. By this point, they are already significantly behind their peers in math and face greater challenges as students and adults. Early screening can detect the risk factors for dyscalculia and math learning problems as early as age 3, allowing for intervention and support. We have developed a screening tool and identified evidence-based interventions for educators, parents, and administrators to help each child. We urge states, districts, educators, parents, researchers, and advocates to prioritize early math screening, just as they do for vision, hearing, and dyslexia. To truly support our students as they journey through their educational careers and prepare to enter the workforce, particularly with careers tied to STEM education, we must address the fundamental skills necessary for success, which include math.”

Dyscalculia is a math learning disability that affects a person’s ability to understand and work with numbers and number related concepts and can lead to various other difficulties with mathematics, from math anxiety to math avoidance. It is not gender specific and is dramatically under-identified compared to dyslexia. In addition, up to 70% of individuals who have been identified as dyslexic are estimated to also have dyscalculia.

The Analysis Includes Critical Key Points Driven by Research, Including:

Dyslexia vs. dyscalculia:

• In the last 20 years, there has been a push to address illiteracy through early identification with universal screeners, but the same focus has not been there for innumeracy. Even with the increased need for math skills due to technology, there have not been national campaigns to address the problem (Bryant, 2008; De Visscher, 2018; National Center for Education Statistics, 2022).

Importance of early identification and intervention:

• Early identification in the years preceding 3rd grade and intervention in the specific math problem areas is effective and yields the best prognosis for students (Haberstroh & Schulte-Korne, 2019).
• With early intervention and the right supports, including accommodations and modifications, it is very possible to adapt to being dyscalculic, demonstrate mastery of mathematics and succeed as a student and adult (Bailey et al., 2020).

Screening for dyscalculia:

• TouchMath designed the DySc screener as a free, online tool that teachers or guardians can easily administer.
• The DySc generates a report that includes an action plan and recommended evidence-based interventions.

“TouchMath is dedicated to increasing awareness of dyscalculia while offering accessible tools to empower every student to unlock their true potential,” stated Sean Lockwood, CEO of TouchMath. “This whitepaper bridges the gap between research and early intervention, laying the foundation for our vision where every student receives screening before starting school and is equipped for grade-level success.”

To view the whitepaper, visit this link.

To learn more about supporting learners with dyscalculia, visit touchmath.com/dyscalculia-101.

About TouchMath

TouchMath provides a wide range curriculum and tools for educators and their students who struggle to understand grade-level content. TouchMath is committed to maximizing student potential through its worldwide delivery of hands-more, visit https://touchmath.com/.

Share article on social media or email: